山东新华制药股份(00719)终止收购挪亚圣诺(太仓)生物科技有限公司股权

智通财经
Feb 06

智通财经APP讯,山东新华制药股份(00719)发布公告,有关本公司与挪亚圣诺(欧洲)公司签署《股权收购意向协议》。股权收购意向协议仅系各方经友好协商达成的初步意向,然而,经进一步讨论及磋商后,订约方未能就正式协议的条款及条件达成共识。本公司因此并无就该项目订立正式协议,该项目亦不会进行。故此,本公司已决定终止该等股权收购意向协议。

终止《股权收购意向协议》系本公司审慎研究后作出的决定,不会影响本公司现有生产经营活动,也不会对本公司的发展造成不利影响,不存在损害本公司及全体股东,特别是中小股东利益的情形。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10